Related by context. All words. (Click for frequent words.) 79 dacarbazine 79 FOLFIRI 79 pegylated liposomal doxorubicin 78 FOLFOX 77 paclitaxel carboplatin 77 5-FU/LV 77 Fludara 75 gemcitabine Gemzar 75 pegylated interferon alfa 2b 75 nab paclitaxel 75 docetaxel chemotherapy 75 FOLFOX4 75 low dose cytarabine 75 melphalan prednisone 75 gemcitabine carboplatin 75 gemcitabine chemotherapy 75 cisplatin vinorelbine 75 docetaxel 74 chlorambucil 74 azathioprine 74 interferon alfa 2a 74 lopinavir r 74 chemoradiotherapy 74 mapatumumab 74 daunorubicin 74 gemcitabine 74 sorafenib Nexavar ® 74 XELOX 73 Taxotere ® 73 plus gemcitabine 73 Peg IFN 73 goserelin 73 comparator arm 73 5FU 73 topotecan 73 capecitabine 73 Doxil ® 73 doxorubicin cyclophosphamide 73 pemetrexed 73 carboplatin 73 bevacizumab Avastin ® 73 Irinotecan 73 5 FU leucovorin 73 mycophenolate mofetil 73 Imprime PGG 73 FOLFOX6 73 DOXIL 73 pertuzumab 72 alfa 2a 72 mRCC 72 CHOP chemotherapy 72 fluorouracil 72 vinorelbine 72 idarubicin 72 temsirolimus 72 adriamycin 72 docetaxel Taxotere 72 plus dexamethasone 72 platinum refractory 72 gemcitabine cisplatin 72 pegylated interferon alfa 2a 72 plus prednisone 72 sorafenib Nexavar 72 mitoxantrone 72 tenofovir emtricitabine 72 Taxotere R 72 fluoropyrimidine 72 Folfox 72 oral diclofenac 72 trastuzumab Herceptin R 71 Gemcitabine 71 ribavirin RBV 71 #mg/m# [001] 71 ritonavir boosted 71 irinotecan chemotherapy 71 standard chemotherapy regimen 71 5 fluorouracil 71 cyclophosphamide doxorubicin vincristine 71 zalutumumab 71 capecitabine Xeloda 71 peginterferon alfa 2b 71 mitomycin 71 metastatic CRC 71 docetaxel Taxotere R 71 neoadjuvant chemotherapy 71 peginterferon alfa 2a 71 estramustine 71 placebo dexamethasone 71 5 fluorouracil leucovorin 71 chemoradiation 71 saline placebo 71 pomalidomide 71 infusional 5-FU/LV 70 metastatic GIST 70 telaprevir dosed 70 dacarbazine DTIC 70 lenalidomide dexamethasone 70 interferon alfa 2b 70 oral clodronate 70 dexamethasone Decadron 70 Pemetrexed 70 bevacizumab Avastin 70 bendamustine 70 erlotinib Tarceva ® 70 #mg BID [001] 70 Capecitabine 70 metastatic renal cell carcinoma 70 clodronate 70 docetaxel Taxotere ® 70 chemotherapy docetaxel 70 HER2 positive metastatic breast 70 cytarabine 70 FOLPI 70 temozolomide 70 PEG interferon 70 postoperative chemotherapy 70 oblimersen 70 ABVD 70 cytotoxic chemotherapy 70 Copegus ribavirin 70 bevacizumab 70 irinotecan doxorubicin oxaliplatin paclitaxel 70 cisplatin chemotherapy 70 paclitaxel Taxol ® 70 decitabine 70 active comparator 70 KRAS mutations occur 70 lenalidomide Revlimid R 70 Gemzar ® 70 Cytoxan 70 Bevacizumab 70 TORISEL 70 PREZISTA r 70 docetaxel prednisone 70 VELCADE melphalan 70 PREZISTA rtv 70 Peginterferon 70 evaluating tivozanib 70 cyclophosphamide 69 cabazitaxel 69 HRPC 69 trastuzumab 69 idraparinux 69 chemoradiation therapy 69 oral allopurinol 69 Proxinium TM 69 FluCAM 69 Pegasys ® 69 FUSILEV enhances 69 heavily pretreated patients 69 galiximab 69 Panzem R NCD 69 epirubicin cyclophosphamide 69 neurologic progression 69 Amrubicin 69 low dose dexamethasone 69 pamidronate 69 cisplatin gemcitabine 69 dose cytarabine 69 trabectedin 69 Aflibercept 69 BEACOPP 69 sunitinib malate 69 FOLFOX6 chemotherapy regimen 69 epirubicin 69 cyclophosphamide methotrexate 69 cetuximab 69 CIMZIA TM 69 chemotherapy cisplatin 69 taxane chemotherapy 69 relapsed refractory multiple myeloma 69 Alkeran 69 cetuximab Erbitux R 69 liposomal doxorubicin 69 PegIFN 69 carboplatin chemotherapy 69 boosted protease inhibitor 69 oxaliplatin 69 LPV r 68 APTIVUS r 68 paclitaxel chemotherapy 68 refractory multiple myeloma 68 Camptosar ® 68 salmeterol fluticasone 68 5 Fluorouracil 68 Doxil 68 bevacizumab Avastin R 68 FOLFIRI alone 68 abacavir lamivudine 68 paclitaxel Taxol 68 TAXOTERE R 68 adalimumab 68 sorafenib Nexavar R 68 axitinib 68 Targretin 68 Paraplatin ® 68 dose dexamethasone 68 ritonavir boosted atazanavir 68 Elitek 68 Hycamtin ® 68 fluorouracil leucovorin 68 ELOXATIN 68 μg dose 68 DMARDs 68 azacytidine 68 standard chemotherapy regimens 68 COPEGUS 68 q#h 68 Xeloda ® 68 Herceptin trastuzumab 68 anthracycline taxane 68 Xelox 68 mg BID 68 infliximab monotherapy 68 peg IFN 68 mg m² 68 relapsed MM 68 dasatinib Sprycel ® 68 vandetanib 68 CANCIDAS 68 mitoxantrone plus 68 monotherapy 68 4mg/kg 68 recurrent GBM 68 etoposide 68 SCCHN 68 OncoVEX GM CSF 68 bortezomib 68 unfractionated heparin 68 ibandronate 68 cisplatin 68 leucovorin 68 DAPT 68 fludarabine 68 pegylated interferon alpha 68 Flu Cy 68 Torisel 68 eptifibatide 68 azacitidine 68 Platinol 68 mg QD 68 thalidomide Thalomid 68 neoadjuvant 68 unresectable stage 68 dasatinib 68 interferon alfa 68 HGS# 68 iniparib 68 TACE 68 stage IIIB 68 locoregional recurrence 68 alpha 2a 68 octreotide LAR 67 temozolomide TMZ 67 aflibercept 67 sorafenib 67 mcg albinterferon alfa 2b 67 pegylated interferon alfa 67 gefitinib 67 unfractionated heparin UFH 67 interferon ribavirin 67 CYPHER Stent 67 MGd 67 adjuvant radiation 67 Aptivus ® 67 q8h 67 Tarceva erlotinib 67 ACTEMRA TM 67 recurrent metastatic 67 biologic DMARD 67 Trastuzumab 67 Ceplene/IL-2 67 Carboplatin 67 Fludarabine 67 squamous histology 67 unresectable 67 Taxotere docetaxel 67 NRTIs 67 TELCYTA 67 metastatic RCC 67 cytarabine daunorubicin 67 refractory AML 67 relapsed ovarian cancer 67 sunitinib 67 debulking surgery 67 FASLODEX 67 Pegasys peginterferon alfa 2a 67 efavirenz EFV 67 mg kg dose 67 relapsed CLL 67 trastuzumab Herceptin ® 67 flutamide 67 Fluorouracil 67 Pegylated Interferon 67 cediranib 67 bortezomib Velcade R 67 APTIVUS 67 imipenem 67 CIMZIA ™ 67 recurrent glioblastoma multiforme 67 piperacillin tazobactam 67 rituximab 67 IFN alfa 67 Fludara ® 67 oral ridaforolimus 67 capecitabine Xeloda R 67 forodesine 67 DMARD 67 HGS ETR2 67 darunavir ritonavir 67 melphalan 67 sorafenib tablets 67 seliciclib 67 ixabepilone 67 paclitaxel 67 mcg kg 67 tirofiban 67 adecatumumab 67 irbesartan 67 lopinavir r arm 67 LEXIVA r 67 refractory metastatic colorectal cancer 67 FOLFOX4 alone 67 Lenalidomide 67 HGS ETR1 67 plus prednisone prednisolone 67 radiotherapy RT 67 adalimumab Humira 67 recurrent NSCLC 67 MAGE A3 ASCI 67 concurrent chemoradiation 67 paclitaxel cisplatin 67 mg/m2 dose 67 PegIFN RBV 67 infusional 67 metastatic hormone refractory 67 8mg/kg 67 postmenopausal osteoporotic women 67 valopicitabine 67 doxorubicin 67 PegIntron 67 cetuximab Erbitux 67 comparator PI r 67 cell lymphoma CTCL 67 chemotherapy FOLFOX 67 peginterferon alpha 2a 67 Tarceva TM 67 metformin sulfonylurea 67 neoadjuvant treatment 66 prednisone prednisolone 66 fluticasone salmeterol 66 administered subcutaneously 66 stage IIIb IV 66 sirolimus eluting stent 66 Velcade bortezomib 66 teriflunomide 66 zonisamide SR 66 metastatic HRPC 66 alpha interferons 66 ZACTIMA 66 CAELYX 66 mcg QD 66 relapsed multiple myeloma 66 CLL SLL 66 Allovectin 7 ® 66 metastatic malignant melanoma 66 #mg BID [003] 66 zoledronic acid 66 gemcitabine Gemzar ® 66 Free Survival PFS 66 Alocrest 66 Adjuvant chemotherapy 66 overlapping toxicities 66 CR nPR 66 bicalutamide 66 hepatic metastases 66 ara C 66 Vicinium TM 66 Epirubicin 66 gefitinib Iressa 66 fallopian tube carcinoma 66 cyclophosphamide chemotherapy 66 ARB telmisartan 66 metastatic colorectal carcinoma 66 PEG IFN 66 systemic ALCL 66 cilengitide 66 relapsed refractory 66 doxorubicin docetaxel 66 dacarbazine chemotherapy 66 posaconazole 66 atazanavir ritonavir 66 pegylated interferon 66 methotrexate monotherapy 66 certolizumab 66 oral Xeloda 66 PSMA ADC 66 levosimendan 66 Etoposide 66 cetuximab Erbitux ® 66 aflibercept VEGF Trap 66 median PFS 66 interferon gamma 1b 66 imetelstat 66 Erlotinib 66 oral rivaroxaban 66 paclitaxel Taxol R 66 achieved ACR# 66 timolol 66 ALA PDT 66 amoxicillin clavulanate 66 cancer mCRC 66 Mitoxantrone 66 receptor tyrosine kinase inhibitor 66 neoadjuvant therapy 66 injected subcutaneously 66 KRAS wild 66 glatiramer acetate 66 alpha 2b 66 glufosfamide 66 Neoadjuvant 66 PEGINTRON TM 66 hormone refractory metastatic prostate 66 Pegasys plus Copegus 66 nilotinib 66 ribavirin therapy 66 metaglidasen 66 pegfilgrastim 66 adjuvant therapy 66 IFN α 66 tacrolimus ointment 66 telaprevir dosing 66 Oxaliplatin 66 aspirin clopidogrel 66 lapatinib Tykerb 66 alkylating agent 66 Bezielle 66 plus ribavirin 66 BRAF inhibitor 66 aspirin heparin 66 folinic acid 66 phase IIb clinical 66 BRIM2 66 dose regimens 66 immunomodulatory therapy 66 5 FU 65 mCRC patients 65 oxycodone CR 65 thymalfasin 65 gemtuzumab ozogamicin 65 interferon beta 1a 65 relapsing multiple sclerosis 65 rosuvastatin #mg 65 bortezomib Velcade 65 leukemia AML 65 biologic therapy 65 pegylated liposomal doxorubicin PLD 65 neratinib 65 locoregional 65 non squamous NSCLC 65 FOLFOX chemotherapy 65 AZT zidovudine Retrovir 65 EFAPROXYN 65 Platinol ® 65 preoperative chemotherapy 65 pegylated interferon peg IFN 65 Neulasta ® 65 FOLFOX regimen 65 enzastaurin 65 YONDELIS 65 chemoembolization 65 glargine 65 rizatriptan 65 intravenous bisphosphonates 65 RLAI 65 dasatinib Sprycel 65 5-fluorouracil/leucovorin 65 heavily pretreated 65 mcg BID 65 dexamethasone 65 dose escalation 65 TRAIL R1 65 pharmacologically active isomer 65 pancreatic adenocarcinoma 65 tamoxifen Nolvadex ® 65 GP IIb IIIa inhibitors 65 evaluable patients 65 plus methotrexate 65 IMC A# 65 cisplatin carboplatin 65 Platinol ® cisplatin 65 Interferon alfa 65 uric acid lowering 65 GW# [003] 65 peginterferon 65 angiotensin converting enzyme inhibitor 65 NRTI 65 TO AVOID PREGNANCY WHILE 65 tumor xenograft models 65 paclitaxel poliglumex 65 TroVax ® 65 mg TID 65 erlotinib 65 vincristine doxorubicin 65 Navelbine 65 #Gy 65 voriconazole 65 peginterferon alfa 2a Pegasys 65 iodixanol 65 plus 5-FU/LV 65 Taxotere chemotherapy 65 3TC lamivudine Epivir 65 relapsed myeloma 65 Docetaxel 65 oral levofloxacin 65 vinca alkaloid 65 dalteparin 65 immunoconjugate 65 #mg q8h 65 SPRYCEL ® 65 Gliadel Wafer 65 Hazard Ratio 65 tamsulosin 65 protease inhibitor PI 65 mg subcutaneously 65 CA4P 65 ceftazidime 65 nadolol 65 NXL# 65 EBRT 65 rFSH 65 paclitaxel eluting stents 65 assessing T DM1 65 mitoxantrone chemotherapy 65 elotuzumab 65 oral chemotherapeutic agent 65 metastatic colorectal 65 Ixempra 65 antithymocyte globulin 65 lispro 65 metastatic malignant 65 celgosivir 65 Metastatic Colorectal Cancer 65 abciximab 65 refractory chronic lymphocytic 65 metastatic pancreatic 65 Toxicities 65 PEGylated Fab fragment 65 imatinib Gleevec 65 taxane 65 RSR# efaproxiral 65 taxotere 65 #mg/m# [002] 65 Q2W 65 ZOLINZA 65 BENICAR HCT 65 temsirolimus Torisel ® 65 pyridostigmine 65 EndoTAGTM 1 65 pazopanib 65 weekly subcutaneous injections 65 luteinizing hormone releasing 65 pegylated interferon alpha 2a 65 Vidaza azacitidine 65 HuMax EGFr 65 #mg QD [001] 65 INC# 65 xanthine oxidase inhibitor 65 VNP#M 65 pimecrolimus 65 tiotropium 64 Taxotere 64 continuous intravenous infusion 64 oxaliplatin Eloxatin 64 ARIMIDEX 64 anastrozole 64 PREZISTA ritonavir 64 Traficet EN 64 angiotensin receptor blocker ARB 64 visilizumab 64 T DM1 64 Xanafide 64 Pharmacokinetics PK 64 Taxol paclitaxel 64 bosutinib 64 relapsed SCLC 64 Cisplatin 64 pyrazinamide 64 primary hypercholesterolemia 64 iniparib BSI 64 3mg/kg 64 YERVOY 64 eplerenone 64 Pertuzumab 64 chemotherapy gemcitabine 64 AGILECT R 64 DMARDS 64 regorafenib 64 Zorbtive TM 64 Fulvestrant 64 SCH # 64 irinotecan 64 nitazoxanide 64 Peginterferon Alfa 2a 64 fosamprenavir 64 letrozole Femara 64 DOXIL ® 64 Seliciclib 64 somatostatin analog 64 Bortezomib 64 NATRECOR R 64 locoregional disease 64 insulin detemir 64 fulvestrant 64 anthracycline containing 64 fallopian tube cancers 64 Topotecan 64 advanced hepatocellular carcinoma 64 sunitinib Sutent ® 64 evaluating T DM1 64 calcineurin inhibitors 64 oral vancomycin 64 oral deforolimus 64 TNF inhibitor 64 tipranavir 64 tipranavir r 64 ELACYT 64 hydroxymethyl coenzyme 64 ABC/3TC 64 Xeloda capecitabine 64 fluconazole 64 Paraplatin ® carboplatin 64 EGFR expressing 64 xenograft models 64 adjuvant tamoxifen 64 Pegintron 64 chemotherapeutic drug 64 #:# randomization 64 lymphadenectomy 64 antiandrogen 64 Melphalan 64 remission induction 64 antithrombotics 64 afatinib 64 abiraterone acetate 64 noninferior 64 free survival PFS 64 SCIg 64 tanespimycin 64 metastatic castration resistant 64 refractory NSCLC 64 virologic failure 64 β blockers 64 pCR 64 radiochemotherapy 64 zidovudine lamivudine 64 Combo Stent 64 metastatic colorectal cancer 64 custirsen 64 Sandostatin R 64 Rebif ® 64 patients evaluable 64 amrubicin 64 vorinostat 64 tocilizumab 64 TYKERB 64 Angiomax monotherapy 64 TELINTRA 64 enfuvirtide 64 mg ustekinumab 64 darunavir r 64 antiangiogenic therapy 64 Viread Emtriva 64 oral Hycamtin 64 INTELENCE 64 NMIBC 64 Telintra 64 partial remissions 64 Pegylated interferon 64 TMC# r 64 chemotherapy regimens 64 pan HDAC inhibitor 64 nucleoside analog 64 Cloretazine R VNP#M 64 PEG INTRON 64 nicardipine 64 CYT# potent vascular disrupting 64 micafungin 64 febuxostat 64 PD LID 64 Cloretazine 64 Caelyx 64 alefacept 64 imatinib 64 mCi kg 64 ethambutol 64 EGFR mutation positive 64 Navelbine ® 64 mg qd 64 raltegravir 64 platelet inhibitor 64 tigecycline 64 ® lenalidomide 64 DEB# 64 Hycamtin 64 CIMZIA TM certolizumab pegol 64 trans retinoic acid ATRA 64 Targretin capsules 64 TTF Therapy 64 LMWH 64 vicriviroc 64 doxazosin 64 interferon α 64 mg administered orally 64 Taxol ® 64 Erbitux cetuximab 64 viral kinetics 64 NSCLC 64 Peginterferon alfa 2b 64 antibody MAb 64 evaluating Xcytrin 64 pegylated interferons 64 anti EGFR antibody 64 adjuvant radiotherapy 64 imatinib Gleevec ® 64 dosing cohorts 64 candesartan cilexetil 64 Hormone Refractory Prostate Cancer 64 FEMALES SHOULD BE ADVISED 64 zoledronate 64 Gefitinib 64 Elotuzumab 64 SUTENT 64 R# #mg BID 64 TNF antagonists 64 ATACAND 64 FIRMAGON 64 prostate cancer HRPC 64 steroid dexamethasone 64 rFVIIa 64 Combination therapy 64 follicular NHL 64 tesmilifene 64 basal cell carcinoma BCC 64 Campath alemtuzumab 64 baminercept 64 Gemzar gemcitabine 64 #.#mg/dL 64 demonstrated antitumor activity 64 AVASTIN 64 cilostazol 64 mycophenolate mofetil MMF 64 ARCALYST ® 64 GnRH agonists 64 deferoxamine 64 cobicistat 64 adjuvant chemotherapy 64 anti leukemic 64 Pegylated Liposomal Doxorubicin 64 maximally tolerated dose 64 INCB# [001] 64 adefovir dipivoxil 64 HBeAg seroconversion 64 etanercept Enbrel 64 Xeloda 64 DFMO 64 raloxifene Evista 64 etanercept 64 caspofungin 64 PKC# 64 mcg dose 64 PEGASYS ® 63 Revlimid lenalidomide 63 resminostat 63 sustained virological response 63 bleomycin 63 CLARITY study 63 verteporfin 63 antitumor activity 63 MabCampath 63 dose cohorts 63 vinorelbine tartrate 63 VICTRELIS 63 DU #b 63 antimetabolite 63 HERCEPTIN 63 nucleoside reverse transcriptase inhibitor 63 Zyclara 63 Jevtana 63 peg interferon 63 hA# 63 titrated glipizide 63 biochemical relapse 63 TEMODAL 63 invasive candidiasis 63 ribavirin USP 63 CCX# B 63 alfa 2b 63 IV bolus 63 AVONEX ® 63 Cloretazine ® 63 liposomal amphotericin B 63 PEGINTRON 63 Bevacizumab Avastin 63 relapsed refractory AML 63 dosage regimens 63 adefovir 63 receiving VICTRELIS 63 imiquimod cream 63 recurrent malignant glioma 63 trastuzumab Herceptin 63 dabigatran etexilate 63 systemic antifungal 63 Proleukin 63 XGEVA 63 VIRAMUNE 63 cyclophosphamide Cytoxan 63 ritonavir boosted lopinavir 63 chlorthalidone 63 Rituxan rituximab 63 mertansine 63 imatinib therapy 63 HBeAg negative 63 BAY #-# 63 mTOR inhibitor 63 advanced NSCLC 63 nilotinib Tasigna ® 63 sargramostim 63 IMGN# 63 chemotherapeutic regimens 63 LHRH 63 virologic response 63 Vidaza ® 63 Femara letrozole 63 sulphonylurea 63 elacytarabine 63 mCRC 63 refractory CTCL 63 mTOR inhibitors 63 external beam radiotherapy 63 eribulin 63 Avastin bevacizumab 63 miconazole Lauriad ® 63 advanced unresectable 63 #mg QD [002] 63 sevelamer 63 TREANDA 63 HCV RESPOND 2 63 chemotherapeutic regimen 63 Luteinizing Hormone Releasing Hormone 63 dextromethorphan quinidine 63 Sanofi Aventis Taxotere 63 intravenous REOLYSIN 63 ribavirin Copegus ® 63 Nexavar ® 63 TDF FTC 63 BARACLUDE ® 63 INTEGRILIN R 63 tiotropium bromide 63 Natalizumab 63 lipid lowering agents 63 lapatinib 63 bexarotene 63 COMBIVIR 63 atorvastatin #mg 63 cyclophosphamide vincristine 63 reinfarction 63 apremilast 63 intra arterial chemotherapy 63 gadobutrol 63 conventional DMARDs 63 triamcinolone 63 subcutaneously administered 63 exemestane Aromasin 63 insulin glargine 63 complete cytogenetic response 63 Protelos 63 severe neutropenia 63 tolvaptan 63 trans retinoic acid 63 imatinib resistant 63 octreotide acetate 63 PEG Interferon alfa 63 sustained virologic response 63 genotypic resistance 63 abatacept Orencia 63 trials RCTs 63 KRAS mutant tumors 63 lexidronam injection 63 resectable 63 potent CYP#A# inhibitors 63 thiazide diuretic 63 sunitinib Sutent 63 vidofludimus 63 clopidogrel Plavix 63 APTIVUS R 63 humanised monoclonal antibody 63 DCVax ® Brain 63 olaparib 63 Cyclophosphamide 63 Neulasta R 63 doublet chemotherapy 63 budesonide 63 Engerix B 63 colesevelam HCl 63 infliximab 63 EGFR TKI 63 DMARD therapy 63 antiarrhythmic drug 63 Copegus 63 Clolar ® 63 stavudine d4T 63 irinotecan cisplatin 63 IIIa inhibitor 63 Ibritumomab Tiuxetan 63 TPV r 63 Thal Dex 63 fluticasone propionate 63 Temsirolimus 63 fluvastatin 63 recurrent squamous cell carcinoma 63 Nexavar sorafenib 63 epoetin beta 63 HBeAg positive patients 63 CTAP# Capsules 63 R Saizen R 63 CRp 63 ULORIC 63 amphotericin B 63 androgen deprivation 63 CsA 63 fluticasone furoate 63 huN# DM1 63 Pazopanib 63 imiquimod 63 evaluable 63 indolent NHL 63 Interferon alpha 63 p = NS 63 REVLIMID ® 63 CoFactor 63 ErbB2 positive 63 cidofovir 63 corticosteroid dexamethasone 63 doxorubicin HCl liposome injection 63 KRN# 63 Leukine ® 63 lenalidomide 63 Median progression 63 biliary tract cancer 63 -#.# log# 63 Pegasys R 63 definite stent thrombosis 63 VELCADE 63 everolimus eluting stents 63 DAVANAT 63 metastatic gastric 63 Neupogen ® 63 HBeAg positive 63 TRIZIVIR 63 EndoTAG 63 alpha blocker 63 Rituxan MabThera 63 AEGR 63 sotalol 63 adjunctive placebo 63 evaluating satraplatin 63 bupropion SR 63 TLK# 63 oral antidiabetic 63 enalapril 63 mg/m2/day 63 OPAXIO 63 TAXOTERE ® 63 Sandostatin LAR 63 Tamibarotene 63 resectable pancreatic cancer 63 Diovan HCT 63 prostate cancer CRPC 63 PEG Intron 63 unresectable locally advanced 63 pharmacodynamic properties 63 Darusentan 63 lumbar spine BMD 63 tamoxifen therapy 63 abacavir Ziagen 63 thromboembolic events 63 hypofractionated 63 NEVO ™ 63 Degarelix 63 PEGylated interferon beta 1a 63 crizotinib PF # 63 remission CR 63 PRT# 63 Phase Ib II 63 anti angiogenic agents 62 ALGRX 62 advanced nonsquamous NSCLC 62 REBETOL